New wave · Worldwide

New AI drug discovery startups, founded 2020 on

The new wave: 68 AI drug discovery startups founded in 2020 or later that have raised money in rounds we track, $5.9B between them, placed in 4 segments.

68startups on the map
4segments
$5.9Braised between them
AI discovery platformsmost funded segment

AI discovery platforms

44

+20 more

Protein design

9

Small molecules

9

Antibodies and biologics

6

Segment by segment

AI discovery platforms

44 startups · $4.8B raised

  1. Isomorphic LabsIsomorphic Labs is a London-based artificial intelligence company focused on transforming the drug discovery process.United Kingdom$3.1B
  2. Xaira TherapeuticsXaira Therapeutics is an integrated biotechnology company founded in 2023 and publicly launched in April 2024.United States$1.0B
  3. Zephyr AIZephyr AI is a precision medicine and healthcare technology company focused on enhancing drug discovery and clinical trials througUnited States$111M
  4. METiS PharmaceuticalsMETiS Pharmaceuticals is the world's first AI-driven drug formulation company.China$56M
  5. Belharra TherapeuticsBelharra Therapeutics disrupts the drug discovery paradigm with its novel photoaffinity-based chemoproteomics platform.United States$50M
  6. Xellar BiosystemsXellar Biosystems is an AI-driven biotechnology company founded in 2022, based in Cambridge, Massachusetts.United States$50M
  7. AlgorithmiqAlgorithmiq is a quantum software company based in Helsinki, founded in 2020.Finland$37M
  8. Orakl OncologyOrakl Oncology is a French techbio startup founded in 2023 as a spin-off from the Gustave Roussy Institute, a leading cancer research center.France$35M

Protein design

9 startups · $497M raised

  1. SepternaSepterna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.United States$150M
  2. Outpace BioOutpace Bio is a clinical-stage biotechnology company based in Seattle, Washington.United States$144M
  3. BioGeometryBioGeometry is a Beijing-based biotech company that specializes in digital biology and AI applications in protein design and drug discovery.China$100M
  4. Gandeeva TherapeuticsGandeeva Therapeutics is a precision biotechnology company based in Burnaby, British Columbia, Canada, founded in 2021.Canada$40M
  5. GaluxGalux is a biotechnology company based in Seoul, South Korea, founded in 2020.South Korea$29M
  6. ALLOXALLOX is a techbio startup founded in 2023, emerging from Barcelona's Centre for Genomic Regulation.Spain$11M
  7. CTCeleris TherapeuticsHarnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.United States$9.8M
  8. Leash BioLeash Bio, also known as Leash Biosciences, is an AI-native biotechnology company based in Salt Lake City, Utah, founded in 2021.United States$9.3M

Small molecules

9 startups · $590M raised

  1. Terremoto BiosciencesTerremoto Biosciences is a clinical-stage biotechnology company founded in 2021, focused on covalent drug discovery and development.United States$283M
  2. Congruence TherapeuticsCongruence Therapeutics is a Montreal-based biotechnology company founded in 2021 by Clarissa Desjardins, PhD, and Michael Rock Goldsmith.Canada$72M
  3. Kimia TherapeuticsKimia Therapeutics, Inc.United States$55M
  4. Empress TherapeuticsEmpress Therapeutics is a biotechnology company focused on small-molecule drug discovery.United States$50M
  5. Montai TherapeuticsMontai Therapeutics is a biotechnology company based in Cambridge, MA, founded in 2022.United States$50M
  6. XinTheraXinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.United States$50M
  7. MindRank AIMindRank AI is a clinical-stage company based in Shanghai, specializing in AI-powered drug discovery.China$23M
  8. KuanoKuano is a UK-based biotechnology company founded in 2020, specializing in drug discovery.United Kingdom$4.8M

Antibodies and biologics

6 startups · $92M raised

  1. Metaphore BiotechnologiesMetaphore Biotechnologies is a biotechnology company based in Cambridge, Massachusetts, founded in 2021 by Flagship Pioneering.United States$50M
  2. Tahoe TherapeuticsTahoe Therapeutics is a biotechnology company based in South San Francisco, California.United States$30M
  3. immunitoAIimmunitoAI is a TechBio startup founded in 2020, based in Bengaluru, India.India$6.1M
  4. Algorithmic BiologicsAlgorithmic Biologics is a Bengaluru-based startup founded in March 2021 by Dr.United States$2.5M
  5. Kiin BioKiin Bio, legally known as Kiin AI Limited, is a UK-based artificial intelligence company focused on AI-driven drug discovery and United Kingdom$2.2M
  6. SinglomicsSinglomics uses single-cell sequencing technology for antibody drug discovery.-$1.4M

How this map is made. Every startup here has raised money in rounds we track, and was founded in 2020 or later. It joins the map when its sectors, read from its rounds, or the opening of its own description say it works in AI drug discovery, and goes to the first segment whose words it carries. Each segment shows its best-funded first. Rebuilt nightly; updated 15 November 2026.

More market maps

All maps
Market mapAI drug discovery market map162 startups · 4 segments · $10BInvestors mapWho invests in AI drug discovery82 investors · 5 segmentsRaised in 2026AI drug discovery startups that raised in 202635 startups · 3 segments · $3.5BMarket map · United StatesAI drug discovery market map: United States87 startups · 4 segments · $5.5BMarket map · EuropeAI drug discovery market map: Europe43 startups · 3 segments · $3.9BMarket mapMarketing tech market map1,963 startups · 7 segments · $41B

Who backs AI drug discovery?

Open any company for its rounds and investors, or search the investors behind these startups in the app, with filters, lists and exports.

Find their investorsTop lists